Antinociceptive Activity of Methanol Extract of Muntingia calabura Leaves and the Mechanisms of Action Involved

Muntingia calabura L. (family Elaeocarpaceae) has been traditionally used to relieve various pain-related ailments. The present study aimed to determine the antinociceptive activity of methanol extract of M. calabura leaves (MEMC) and to elucidate the possible mechanism of antinociception involved....

Full description

Bibliographic Details
Main Authors: Balan, T (Author), Salleh, MZ (Author), Sani, MHM (Author), Teh, LK (Author), Zakaria, ZA (Author)
Format: Article
Language:English
Series:EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
Online Access:View Fulltext in Publisher
LEADER 02162nam a2200193Ia 4500
001 10.1155-2012-890361
008 220124s2012 CNT 000 0 und d
020 |a 1741-427X 
020 |a 1741-4288 
245 1 0 |a Antinociceptive Activity of Methanol Extract of Muntingia calabura Leaves and the Mechanisms of Action Involved 
490 1 |a EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1155/2012/890361 
520 3 |a Muntingia calabura L. (family Elaeocarpaceae) has been traditionally used to relieve various pain-related ailments. The present study aimed to determine the antinociceptive activity of methanol extract of M. calabura leaves (MEMC) and to elucidate the possible mechanism of antinociception involved. The in vivo chemicals (acetic acid-induced abdominal constriction and formalin-, capsaicin-, glutamate-, serotonin-induced paw licking test) and thermal (hot plate test) models of nociception were used to evaluate the extract antinociceptive activity. The extract (100, 250, and 500 mg/kg) was administered orally 60 min prior to subjection to the respective test. The results obtained demonstrated that MEMC produced significant (P < 0.05) antinociceptive response in all the chemical- and thermal-induced nociception models, which was reversed after pretreatment with 5 mg/kg naloxone, a non-selective opioid antagonist. Furthermore, pretreatment with L-arginine (a nitric oxide (NO) donor), N-G-nitro-L-arginine methyl esters (L-NAME; an inhibitor of NO synthase (NOS)), methylene blue (MB; an inhibitor of cyclic-guanosine monophosphate (cGMP) pathway), or their combination also caused significant (P < 0.05) change in the intensity of the MEMC antinociception. In conclusion, the MEMC antinociceptive activity involves activation of the peripheral and central mechanisms, and modulation via, partly, the opioid receptors and NO/cGMP pathway. 
700 1 0 |a Balan, T  |e author 
700 1 0 |a Salleh, MZ  |e author 
700 1 0 |a Sani, MHM  |e author 
700 1 0 |a Teh, LK  |e author 
700 1 0 |a Zakaria, ZA  |e author 
773 |t EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE  |x 1741-4288  |g 2012